Literature DB >> 26099917

Paracetamol poisoning: beyond the nomogram.

D Nicholas Bateman1.   

Abstract

Paracetamol poisoning is the commonest overdose seen in the UK. The management of patients with paracetamol poisoning has been little changed for the past 40 years, with a weight related dose of antidote (acetylcysteine) and treatment based on nomograms relating paracetamol concentration to time from ingestion. In 2012 the UK Commission on Human Medicines recommended a revision of the nomogram, following the death of a young woman, lowering the treatment threshold for all patients. As a result many more patients were treated. This has resulted in a large increase in admissions and in the proportion suffering adverse reactions to the antidote acetylcysteine since, interestingly, higher paracetamol concentrations inhibit anaphylactoid reactions to the antidote. New approaches to assessing the toxicity of paracetamol are now emerging using new biomarkers in blood. This article discusses new approaches to risk assessment and treatment for paracetamol overdose based on recent research in this area.
© 2015 The British Pharmacological Society.

Entities:  

Keywords:  acetylcysteine; antidotes; aracetamol; biomarkers; poisoning

Mesh:

Substances:

Year:  2015        PMID: 26099917      PMCID: PMC4500323          DOI: 10.1111/bcp.12604

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  36 in total

1.  Risk factors and mechanisms of anaphylactoid reactions to acetylcysteine in acetaminophen overdose.

Authors:  Nasrin Pakravan; W Stephen Waring; Sushma Sharma; Christopher Ludlam; Ian Megson; D Nicholas Bateman
Journal:  Clin Toxicol (Phila)       Date:  2008-09       Impact factor: 4.467

2.  Anaphylactoid reaction to N-acetylcysteine.

Authors:  N G Walton; T A Mann; K M Shaw
Journal:  Lancet       Date:  1979-12-15       Impact factor: 79.321

3.  The chief scientist reports ... prevention of hepatic necrosis following paracetamol overdosage.

Authors:  L F Prescott
Journal:  Health Bull (Edinb)       Date:  1978-07

4.  Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985)

Authors:  M J Smilkstein; G L Knapp; K W Kulig; B H Rumack
Journal:  N Engl J Med       Date:  1988-12-15       Impact factor: 91.245

5.  The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage.

Authors:  L F Prescott; J W Donovan; D R Jarvie; A T Proudfoot
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

6.  Adverse reactions to N-acetylcysteine.

Authors:  D N Bateman; K W Woodhouse; M D Rawlins
Journal:  Hum Toxicol       Date:  1984-10

7.  Cysteamine, methionine, and penicillamine in the treatment of paracetamol poisoning.

Authors:  L F Prescott; G R Sutherland; J Park; I J Smith; A T Proudfoot
Journal:  Lancet       Date:  1976-07-17       Impact factor: 79.321

Review 8.  Adverse reactions associated with acetylcysteine.

Authors:  E A Sandilands; D N Bateman
Journal:  Clin Toxicol (Phila)       Date:  2009-02       Impact factor: 4.467

9.  Comparison of the 20-hour intravenous and 72-hour oral acetylcysteine protocols for the treatment of acute acetaminophen poisoning.

Authors:  Mark C Yarema; David W Johnson; Randall J Berlin; Marco L A Sivilotti; Alberto Nettel-Aguirre; Rollin F Brant; Daniel A Spyker; Benoit Bailey; Dominic Chalut; Jacques S Lee; Amy C Plint; Roy A Purssell; Tim Rutledge; Catherine A Seviour; Ian G Stiell; Margaret Thompson; Jeffrey Tyberg; Richard C Dart; Barry H Rumack
Journal:  Ann Emerg Med       Date:  2009-06-25       Impact factor: 5.721

10.  Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning.

Authors:  L F Prescott; R N Illingworth; J A Critchley; M J Stewart; R D Adam; A T Proudfoot
Journal:  Br Med J       Date:  1979-11-03
View more
  4 in total

1.  Outcomes from massive paracetamol overdose: a retrospective observational study.

Authors:  Daniel J B Marks; Paul I Dargan; John R H Archer; Charlotte L Davies; Alison M Dines; David M Wood; Shaun L Greene
Journal:  Br J Clin Pharmacol       Date:  2017-01-25       Impact factor: 4.335

Review 2.  Evidence for the changing regimens of acetylcysteine.

Authors:  Angela L Chiew; Geoffrey K Isbister; Stephen B Duffull; Nicholas A Buckley
Journal:  Br J Clin Pharmacol       Date:  2015-11-23       Impact factor: 4.335

3.  N-Acetyl cysteine does not prevent liver toxicity from chronic low-dose plus subacute high-dose paracetamol exposure in young or old mice.

Authors:  Alice Elizabeth Kane; Aniko Huizer-Pajkos; John Mach; Catriona McKenzie; Sarah Jayne Mitchell; Rafael de Cabo; Brett Jones; Victoria Cogger; David G Le Couteur; Sarah Nicole Hilmer
Journal:  Fundam Clin Pharmacol       Date:  2016-02-17       Impact factor: 2.748

4.  Circulating acetaminophen metabolites are toxicokinetic biomarkers of acute liver injury.

Authors:  Adb Vliegenthart; R A Kimmitt; J H Seymour; N Z Homer; J I Clarke; M Eddleston; A Gray; D M Wood; P I Dargan; J G Cooper; D J Antoine; D J Webb; S C Lewis; D N Bateman; J W Dear
Journal:  Clin Pharmacol Ther       Date:  2016-11-30       Impact factor: 6.875

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.